Join us for our 8th Annual Joseph Calello Melanoma Scholar virtual lecture with Dr. Charles M. Balch, who has led a distinguished career as a clinical and academic surgical oncologist for the past 41 years as a leading authority in both melanoma and breast cancer.

Dr. Charles M. Balch
Professor, Department of Surgical Oncology - Research, Division of Surgery,
The University of Texas MD Anderson Cancer Center, Houston, TX

8th Annual Joseph Calello Melanoma Scholar Lecture: A Virtual Presentation on The Surgical Management of Melanoma

Topics of discussion at this virtual event include:

Historical clinical trial eligibility considerations in advanced NSCLC

Clinical evidence from one of the largest advanced NSCLC trials conducted to date

Resources to help support your eligible patients

Please join us to learn about a new FDA-approved first-line monotherapy option in advanced NSCLC

A new FDA-approved systemic treatment option

The important role of multidisciplinary consultation in the management of advanced BCC

Results and case studies from a prospective clinical study in locally advanced BCC patients

Mark Agulnik, MD
Section Chief, Sarcoma Oncology H&N Program
City of Hope Medical Center-Duarte, CA

Please join us to learn about the multidisciplinary management of advanced BCC

 OncLive® News Network: On Location - ASCO GU 2021

OncLive® News Network: On Location - ASCO GI 2021

Join OncLive® on December 17th, at 3:00 pm and 5:00 pm EST, to gain insights from leaders from organizations such as West Cancer Center and Stanford Cancer Centers as they discuss shifting treatment paradigm in mBC, and their approach to ensuring success with oral therapy.

New Pathways and Chemotherapeutic Delivery Mechanisms in the Treatment of Metastatic Breast Cancer

What is the rationale and strategy for implementing chemotherapy-free intervals for patients with metastatic colorectal cancer? Join us as our panel of renowned experts, Dr. John Marshall and Dr. Axel Grothey discuss this critical topic and answer your questions.

Incorporating a Chemotherapy-Free Interval in Metastatic Colorectal Cancer

OncLive News Network: On Location — SABCS 2020

OncLive® News Network: On Location – ASH 2020

Join us to learn more about how to navigate the new role of immunotherapy in combination with chemotherapy for the first-line treatment of extensive-stage small cell lung cancer on Thursday, December 3, 2020 at 8:00 PM EST.

First-Line Extensive-Stage Small Cell Lung Cancer: Examining the New Role of Combination Chemotherapy and Immunotherapy

We are pleased to announce the Eighth Annual Giants of Cancer Care

 class of inductees. Join us to honor these 15 individuals for their unmatched genius, their generous compassion, and the countless hours of work they have sacrificed to help their patients.

8th Annual Giants of Cancer Care Awards Ceremony

Join us for a presentation on an FDA-approved treatment option to better treat your patients with advanced cutaneous squamous cell carcinoma 

on Thursday, November 5, 2020 at 7:00 PM EDT.

An FDA-approved treatment option in patients with Advanced Cutaneous Squamous Cell Carcinoma

During this live broadcast, you'll learn about XPOVIO® (selinexor), including an overview of:

Michael W. Schuster, MD, and Hakan Kaya, MD

Join Us to Learn About XPOVIO

Join us to learn more about how the field in HER2+ breast cancer is evolving and hear direct from leading experts, Mohammad Jahanzed, MD, FACP, FASCO, and Reshma L. Mahtani, DO, on Monday, October 26, 2020 at 8 PM EDT.

Therapeutic Considerations in Metastatic HER2+ Breast Cancer

Join us to learn more about how the field in HER2+ breast cancer is evolving and hear direct from leading experts, Mark Daniel Pegram, MD and Julie R. Gralow, MD, on Thursday, October 15, 2020 at 8:00 PM PDT.

Considerations in Metastatic HER2+ Breast Cancer

Join us to learn more about how the field in HER2+ breast cancer is evolving and hear direct from leading experts, Debu Tripathy, MD and Michelina Cairo, MD, on Tuesday, October 13, 2020 at 8:00 PM CDT.

Join us to learn more about how the field in HER2+ breast cancer is evolving and hear direct from leading experts, Sara Tolaney, MD, MPH, and Komal Jhaveri, MD, FACP, on Wednesday, October 7, 2020 at 8 PM EDT.

Join us to learn more about how the field in HER2+ breast cancer is evolving and hear direct from leading experts, Hope Rugo, MD and Sara Hurvitz, MD on Wednesday, October 7, 2020 at 7:30 PM PDT.

In this Onclive® webinar, leading lymphoma experts will discuss the use of new and emerging treatment options for relapsed/refractory diffuse large B-cell lymphoma and how these treatments can help shape individualized treatment plans. Join us Tuesday, September 15, 2020 at 8 PM EDT.

A New Chapter in DLBCL: Uncovering New Treatment Options For Your Patients

In this Onclive® webinar, leading experts will highlight how the field in HER2+ breast cancer is evolving and hear direct from leading experts. Join us Tuesday, September 15, 2020 at 8 PM EST.

Review the role of MRD detection in GI cancer

Explore how the role of MRD is evolving and how this will inform physicians in the future

Discuss the potential impact MRD monitoring and detection has on patients

Webinars